To embrace 2019 World Sleep Day, Somnics Inc. (6633) announce today to participate in the conference held by Taiwan Society of Sleep Medicine on 30-31 March. From communicating with medical professionals, Somnics shares the research studies of iNAP sleep therapy system to raise public awareness on Obstructive Sleep Apnea, also known as OSA, and quality of sleep as well. The ultimate mission is to bring comfortable solution for OSA patients.
Obstructive Sleep Apnea (OSA) is the most common type of Sleep Apnea and is caused by complete or partial obstructions of the upper airway. If a person has the symptoms such as snoring, sleep apnea, nose allergy, face loose, double chin, malocclusion and periodontal disease, no matter how severe it is, there is possibility the patient is suffered from OSA .
Vice President of Somnics Inc. Lynn-Lynn Hung suggests, “once you observe the above sleep-disordered symptoms, it is better to go to hospital to conduct sleep test to verify the likelihood of OSA. If a sleep test is not convenient to arrange, you may add LINE ID: @iNAP to inquire for a quick check-up by utilizing oximeter to examine oxygen desaturation events during sleep, which will enable to understand the severity of OSA.
Most OSA patients become mouth-breather during their sleep and tend to result in snoring. Innovative iNAP creates gentle vacuum within the oral cavity that stabilizes the tongue and soft tissues that frees the airways, so that you will be able to breath normally via nose without obstruction, achieving good sleep experience.For more info about iNAP：https://www.inapsleep.com/